Comparing hospital and telephone follow up for women treated for endometrial cancer (ENDCAT): ENDometrial CAncer Telephone follow up trial)

Comparing hospital and telephone follow up for women treated for endometrial cancer (ENDCAT): ENDometrial CAncer Telephone follow up trial): a randomised controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75220876

Enrollment

256

Registered

2011-10-28

Start date

2012-03-23

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: National Cancer Research Network

Interventions

The total sample size of 256 includes equal distribution between those randomised to the intervention group (telephone follow-up) and those randomised to the control arm (standard care)

Follow Up Length: 24 month(s)

Study Entry : Registration and One or More Randomisations

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Known diagnosis of Stage I endometrial cancer 2. Completed primary treatment (e.g. surgery, radiotherapy, chemotherapy) 3. Attending outpatient clinics for the purposes of routine monitoring and surveillance 4. Access to a telephone 5. No age limitations Gender = female; Target Gender: Female

Exclusion criteria

Exclusion criteria: 1. Known diagnosis of stage II, III or IV endometrial cancer 2. Currently receiving active treatment 3. Taking part in clinical trials that have pre-defined follow-up regimes 4. Auditory problems that inhibit the use of the telephone 5. Cannot speak or understand English where no interpreter services are available

Design outcomes

Primary

Measure	Time frame
Psychological Morbidity; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation	—

Secondary

Measure	Time frame
1. Clinical outcomes (time to detection of recurrence); Timepoint(s): At each telephone/hospital appointment that takes place during study period 2. Efficiency; Timepoint(s): 6 and 12 months post randomisation 3. Patient satisfaction with information; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation 4. Patient satisfaction with service; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation 5. Quality of Life; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation	—

Measure

Time frame

1. Clinical outcomes (time to detection of recurrence); Timepoint(s): At each telephone/hospital appointment that takes place during study period 2. Efficiency; Timepoint(s): 6 and 12 months post randomisation 3. Patient satisfaction with information; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation 4. Patient satisfaction with service; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation 5. Quality of Life; Timepoint(s): Baseline (pre-randomisation), 1st scheduled clinic appointment post randomisation

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026